These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8149346)

  • 1. Expression of plasminogen activator inhibitor type 1 (PAI-1) by HT-29di human large bowel carcinoma cells is modulated as a function of epithelial differentiation.
    Higgins PJ; Lipkin M
    Cancer Lett; 1994 Jan; 76(2-3):167-75. PubMed ID: 8149346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of 1,25-dihydroxyvitamin D3 and its analogs on butyrate-induced differentiation of HT-29 human colonic carcinoma cells and on the reversal of the differentiated phenotype.
    Tanaka Y; Bush KK; Eguchi T; Ikekawa N; Taguchi T; Kobayashi Y; Higgins PJ
    Arch Biochem Biophys; 1990 Feb; 276(2):415-23. PubMed ID: 2306105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of butyrate-induced differentiation of HT-29 human colon carcinoma cells by 1,25-dihydroxyvitamin D3.
    Tanaka Y; Bush KK; Klauck TM; Higgins PJ
    Biochem Pharmacol; 1989 Nov; 38(21):3859-65. PubMed ID: 2688649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of hexafluoro-1,25-dihydroxyvitamin D3 and sodium butyrate combination on differentiation and proliferation of HL-60 leukemia cells.
    Yoshida M; Tanaka Y; Eguchi T; Ikekawa N; Saijo N
    Anticancer Res; 1992; 12(6B):1947-52. PubMed ID: 1363510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor beta 1 and sodium butyrate differentially modulate urokinase plasminogen activator and plasminogen activator inhibitor-1 in human breast normal and cancer cells.
    Dong-Le Bourhis X; Lambrecht V; Boilly B
    Br J Cancer; 1998; 77(3):396-403. PubMed ID: 9472634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy.
    Díaz GD; Paraskeva C; Thomas MG; Binderup L; Hague A
    Cancer Res; 2000 Apr; 60(8):2304-12. PubMed ID: 10786699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of extracellular calcium on colonocytes: evidence for differential responsiveness based upon degree of cell differentiation.
    Buras RR; Shabahang M; Davoodi F; Schumaker LM; Cullen KJ; Byers S; Nauta RJ; Evans SR
    Cell Prolif; 1995 Apr; 28(4):245-62. PubMed ID: 7772641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium butyrate alters the response of a human colon carcinoma cell line to transforming growth factor-beta 1.
    Lewis LR; Levine AE
    Cancer Lett; 1992 Mar; 63(1):33-40. PubMed ID: 1555205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Divergent phenotypic patterns and commitment to apoptosis of Caco-2 cells during spontaneous and butyrate-induced differentiation.
    Mariadason JM; Rickard KL; Barkla DH; Augenlicht LH; Gibson PR
    J Cell Physiol; 2000 Jun; 183(3):347-54. PubMed ID: 10797309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p52(PAI-1) and actin expression in butyrate-induced flat revertants of v-ras-transformed rat kidney cells.
    Higgins PJ; Ryan MP
    Biochem J; 1991 Nov; 279 ( Pt 3)(Pt 3):883-90. PubMed ID: 1953684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IP6-induced growth inhibition and differentiation of HT-29 human colon cancer cells: involvement of intracellular inositol phosphates.
    Yang GY; Shamsuddin AM
    Anticancer Res; 1995; 15(6B):2479-87. PubMed ID: 8669811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Butyrate regulates gene expression of the plasminogen activating system in colon cancer cells.
    Antalis TM; Reeder JA
    Int J Cancer; 1995 Sep; 62(5):619-26. PubMed ID: 7665235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasminogen activator and inhibitor activity in human glioma cells and modulation by sodium butyrate.
    Gross JL; Behrens DL; Mullins DE; Kornblith PL; Dexter DL
    Cancer Res; 1988 Jan; 48(2):291-6. PubMed ID: 3121170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Butyrate-induced alterations of phosphoinositide metabolism, protein kinase C activity and reduced CD44 variant expression in HT-29 colon cancer cells.
    Kopp R; Fichter M; Assert R; Pfeiffer AF; Classen S
    Int J Mol Med; 2009 May; 23(5):639-49. PubMed ID: 19360323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of vitamin D receptor abundance and responsiveness during differentiation of HT-29 human colon cancer cells.
    Zhao X; Feldman D
    Endocrinology; 1993 Apr; 132(4):1808-14. PubMed ID: 8384998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of 1,25-(OH)2D3- and 24,25-(OH)2D3-dependent stimulation of alkaline phosphatase activity by A23187 suggests a role for calcium in the mechanism of vitamin D regulation of chondrocyte cultures.
    Schwartz Z; Langston GG; Swain LD; Boyan BD
    J Bone Miner Res; 1991 Jul; 6(7):709-18. PubMed ID: 1659121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of SPARC expression during butyrate-induced terminal differentiation of cultured human keratinocytes: regulation via a TGF-beta-dependent pathway.
    Ford R; Wang G; Jannati P; Adler D; Racanelli P; Higgins PJ; Staiano-Coico L
    Exp Cell Res; 1993 Jun; 206(2):261-75. PubMed ID: 8500547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genes related to growth and invasiveness are repressed by sodium butyrate in ovarian carcinoma cells.
    Krupitza G; Grill S; Harant H; Hulla W; Szekeres T; Huber H; Dittrich C
    Br J Cancer; 1996 Feb; 73(4):433-8. PubMed ID: 8595156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 17 beta-oestradiol enhances the stimulatory effect of 1,25-dihydroxyvitamin D3 on alkaline phosphatase activity in human osteosarcoma SaOS-2 cells in a differentiation-dependent manner.
    Rao LG; Wylie JN; Kung Sutherland MS; Murray TM
    J Endocrinol; 1996 Jan; 148(1):181-7. PubMed ID: 8568466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasminogen activator inhibitor-1 represses integrin- and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation.
    Kjøller L; Kanse SM; Kirkegaard T; Rodenburg KW; Rønne E; Goodman SL; Preissner KT; Ossowski L; Andreasen PA
    Exp Cell Res; 1997 May; 232(2):420-9. PubMed ID: 9168821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.